Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0085632 (
apathy
)
4,089
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The neuropsychiatric symptoms of old patients with disturbed cerebral metabolism or blood flow mostly lead to great individual difficulties and make those patients difficult to handle: in the family as well as in hospital such patients develop alienation, isolation and therefore adaptation to a social structure deteriorates with time. In the course of a test program for medicinal therapy of this syndrome we studied the efficacy of a vincamine containing formulation (Pervincamin forte retard or Pervincamin ampoules, respectively) on the symptoms of a chronical brain disturbance. The study was randomised double-blind. We found that under the influence of the vincamine formulation the subjective symptoms, such as lack of interest,
apathy
, aggressiveness, raging, psychomotoric retardation, lack of concentration, dysmnesia, decreased with a statistical significance (p less than or equal to 0.05). Also the subjective symptoms, reported by the patients, such as
tinnitus
and vertigo decreased significantly under the treatment with the vincamine preparation. Therefore some of the parameters important for resocialisation and revitalisation of old patients could be influenced in a favourable way. Basing on the good results of our investigations, the treatment of psychiatric disturbances in old patients with vincamine containing drugs seems to be justified.
...
PMID:[Demonstrating the effectiveness of cerebroactive drugs in aged patients. Results of a randomized double-blind study of a vincamine containing special preparation]. 34 87
Patients suffering from distortion of the cervical spine after an acceleration trauma present problems with respect to the correct diagnostic recognition of the existing injuries. To define instability of the craniocervical junction, attention should be given to the position of the dens and the dimension of its subarachnoid space during the entire rotational maneuver. Our diagnosis via functional magnetic resonance imaging (fMRI) with video did not focus on injuries to the ligamentous microstructure as visualized with high-resolution MRI. Our purpose was to demonstrate the cause of instability of the craniocervical junction by direct visualization during fMRI-video technique. Between December 1997 and March 1999, 200 patients were studied using fMRI on a 0.2-Tesla Magnetom Open. Routine evaluation of the extracranial vertebral circulation by MRI angiography as an additional preinvestigative requirement is recommended. The earliest examination time from injury to MRI evaluation was 3 months and the maximum, 5 years (average, 2.6 years). Among the 200 patients investigated, 30 showed instability of the ligamentous dens complex. Of the same 200, 8 (4%) had a complete rupture and 22 (11%) an incomplete rupture of the alar ligament, with instability signs. In another 45 patients (22.5%), fMRI-video showed evidence of instability, and all these patients had coexisting intraligamentous signal pattern variation, probably due to granulation tissue. Eighty patients of the 200 (40%) had signal
indifference
without demonstrable video instability signs, and 43 patients (21.5%) showed no evidence of instability and no signal variation in the alar ligaments. On the basis of recognition of instability and the malfunction of the ligaments, the fibrous capsula, and the tiny dens capsula, we now can distinguish between lesions caused by rotatory trauma to the craniocervical junction and those from classic whiplash injury.
Int
Tinnitus
J 2000
PMID:Functional magnetic resonance imaging--video diagnosis of soft-tissue trauma to the craniocervical joints and ligaments. 1468 32
Background Twenty-five years ago attorneys representing ailing women in class action litigation against silicone breast implant manufacturers made the procedural error of defining silicone-induced toxicity in the courtroom before it was properly studied in the exam room. This aberrant methodology perverted the proper research process, rendered verification of any real disease elusive, and cemented the groundwork for a repeat public health crisis potentially affecting two million women in the USA who possess new silicone gel devices inserted over the past 10 years. Patients and methods Six women, previously well, aged 27 to 53 (mean 42), were recipients of the new generations of cohesive silicone gel-filled breast implants approved for general use by the Food and Drug Administration (FDA) since December of 2006. They averaged seven years of total implantation time, and none experienced implant rupture. Results All six became ill on average 3.5 years from the time of implantation. By seven years the women manifested multiple types of skin rashes, polyarthritis, fatigue, protracted AM stiffness, myalgias, headaches, photosensitivity, hair loss, paresthesias,
tinnitus
, lymphadenopathy, chest pain, cognitive dysfunction, dry eyes, skin pigment changes, itching, muscle twitching, dizziness, nausea, easy bruising, and odor and smell sensitivity. Three of the four who were explanted noted improvement and/or resolution of at least 50% of their total disease manifestations. Conclusions These six women are representative of over 70,000 other breast implant recipients who, over the past three years, have had their new silicone devices permanently removed because of alleged gel-induced toxicity. The recurrence of this public health crisis has been fueled by manufacturers' research fraud, FDA ineptness, faulty informed consent, patient abandonment, proprietary manufacturing secrecy, misleading advertising, physician
indifference
, aberrant research methodology, and lax Congressional oversight.
...
PMID:Destiny rides again: the reappearance of silicone gel-filled breast implant toxicity. 2813 37